Jochem van der Voort van Zyp

Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer

Cédric Draulans, Uulke A. van der Heide, Karin Haustermans et al. · Radiotherapy and Oncology · 2020 · 177 citations · Full text

Medicine, Oncology, Urology +6

Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial

Cédric Draulans, Karin Haustermans, Floris J. Pos et al. · Radiotherapy and Oncology · 2024 · 64 citations · Full text

Medicine, Radiation Oncology, Urology +16

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

Shafak Aluwini, Niven Mehra, Martijn P. Lolkema et al. · European Urology Oncology · 2019 · 46 citations · Full text

Medicine, Oncology, Urology +12

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial

Lisa De Cock, Cédric Draulans, Floris J. Pos et al. · Radiotherapy and Oncology · 2023 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Paxillin modulates squamous cancer cell adhesion and is important in pressure‐augmented adhesion

William Conway, Jochem van der Voort van Zyp, Vijayalakshmi Thamilselvan et al. · Journal of Cellular Biochemistry · 2006 · 35 citations

Life Sciences, Cell Biology, Oncology +17